| JSPR Market Cap History Table | ||||||||||||||||||||||||||||||||||||||
Below is a table of the JSPR market cap history going back to 8/16/2021:
Also see: JSPR Shares Outstanding History and JSPR YTD Return |
JSPR Market Cap History — Jasper Therapeutics Capitalization Over Time
As of 5/11/2026 Jasper Therapeutics has a market cap of 26.37 million. Investors often follow the JSPR market cap history to compare the size of the company over time.
This page shows JSPR market capitalization trends over time, with 18 market cap datapoints presented, dating back to 8/16/2021.
| JSPR Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||
JSPR Historical Market Cap: -24.41% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||
| JSPR Stock Price Chart |
| About Jasper Therapeutics Inc |
| Jasper Therapeutics, Inc. is a clinical-stage biotechnology company. Co. is focused on developing therapeutics targeting mast cell driven diseases, such as Chronic Spontaneous Urticaria (CSU) and Chronic Inducible Urticaria (CIndU). It also has ongoing programs in diseases where targeting diseased hemopoietic stem cells can provide benefits, such as Lower to Intermediate Risk Myelodysplastic Syndrome (LR-MDS), and stem cell transplant conditioning regimens. Co.'s lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (c-Kit) receptor on mast and stem cells. We show 18 historical shares outstanding datapoints in our JSPR shares outstanding history coverage, used to compute JSPR market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing JSPR market cap history over the course of time is important for investors interested in comparing JSPR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of JSPR versus a peer is one thing; comparing JSPR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like JSPR can fluctuate over the course of history. With this page we aim to empower investors researching JSPR by allowing them to research the JSPR market cap history. |
| JSPR Current Stock Quote |
Quotes delayed 20 minutes  Free JSPR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| JSPR Share Performance |
| Market Cap Peers |
| Jasper Therapeutics (JSPR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
JUNS Market Cap History KA Market Cap History KALA Market Cap History KALV Market Cap History KDMN Market Cap History KDNY Market Cap History KEQU Market Cap History KERX Market Cap History KIDS Market Cap History KIN Market Cap History More Healthcare companies » |
JSPR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
